News

PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways

Abstract Poliovirus receptor-related 2 (PVRL2, also known as nectin-2 or CD112) is believed to act as an immune checkpoint protein in cancer; however, most insight into its role is inferred from studies on its known receptor, poliovirus receptor (PVR)-related immunoglobulin domain protein (PVRIG,…

AI is a viable alternative to high throughput screening: a 318-target study

Dean’s Award for Excellence in Mentoring

@RyanBoileau was one of three UCSF graduate students recognized for their excellence in peer mentoring. See the full story at here.

Brian DeVeale: Nature Communications "G1/S restriction point coordinates phasic gene expression and cell differentiation"

DeVeale B, Liu L, Boileau R, Swindlehurst-Chan J, Marsh B, Freimer JW, Abate A, Blelloch R. G1/S restriction point coordinates phasic gene expression and cell differentiation. Nat Commun. 2022 Jun 27;13(1):3696. doi: 10.1038/s41467-022-31101-0. PMID: 35760790; PMCID: PMC9237072.

Carolyn Receives Burroughs Wellcome Award

We are proud to announce that Carolyn received the 2022 BWF Career Award for Medical Scientist

Congratulations Dr. Bryan Marsh, PhD

Bryan Marsh, DSCB program, defended his thesis on May 6, 2022. Bryan will start his post-doctoral fellowship in the lab of Dr. Fred De Sauvage in the Molecular Oncology Department at Genentech in June. Congratulations Bryan!